NeuBase Therapeutics, Inc. Quarterly Return On Assets in % from Q1 2012 to Q3 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
NeuBase Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q3 2023.
  • NeuBase Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2023 was -62.4 %, a 17.5% increase year-over-year.
  • NeuBase Therapeutics, Inc. annual Return On Assets for 2022 was -75.7 %, a 42.7% decline from 2021.
  • NeuBase Therapeutics, Inc. annual Return On Assets for 2021 was -53 %, a 31.2% increase from 2020.
  • NeuBase Therapeutics, Inc. annual Return On Assets for 2020 was -77.1 %, a 83.9% increase from 2019.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2023 -62.4 +13.3 +17.5% Jul 1, 2023 Sep 30, 2023
Q2 2023 -76.6 -13.2 -20.7% Apr 1, 2023 Jun 30, 2023
Q1 2023 -82.1 -26.2 -46.8% Jan 1, 2023 Mar 31, 2023
Q4 2022 -82.7 -29.4 -55.1% Oct 1, 2022 Dec 31, 2022
Q3 2022 -75.7 -22.7 -42.7% Jul 1, 2022 Sep 30, 2022
Q2 2022 -63.4 -6.76 -11.9% Apr 1, 2022 Jun 30, 2022
Q1 2022 -55.9 -0.64 -1.16% Jan 1, 2022 Mar 31, 2022
Q4 2021 -53.3 +7.68 +12.6% Oct 1, 2021 Dec 31, 2021
Q3 2021 -53 +24.1 +31.2% Jul 1, 2021 Sep 30, 2021
Q2 2021 -56.7 +138 +70.9% Apr 1, 2021 Jun 30, 2021
Q1 2021 -55.3 +269 +83% Jan 1, 2021 Mar 31, 2021
Q4 2020 -61 +308 +83.5% Oct 1, 2020 Dec 31, 2020
Q3 2020 -77.1 +401 +83.9% Jul 1, 2020 Sep 30, 2020
Q2 2020 -195 +303 +60.8% Apr 1, 2020 Jun 30, 2020
Q1 2020 -325 -105 -47.6% Jan 1, 2020 Mar 31, 2020
Q4 2019 -369 -257 -230% Oct 1, 2019 Dec 31, 2019
Q3 2019 -478 -392 -452% Jul 1, 2019 Sep 30, 2019
Q2 2019 -497 -443 -811% Apr 1, 2019 Jun 30, 2019
Q1 2019 -220 -161 -271% Jan 1, 2019 Mar 31, 2019
Q4 2018 -112 -36 -47.4% Oct 1, 2018 Dec 31, 2018
Q3 2018 -86.6 -5.22 -6.42% Jul 1, 2018 Sep 30, 2018
Q2 2018 -54.6 +30.4 +35.8% Apr 1, 2018 Jun 30, 2018
Q1 2018 -59.3 +38.1 +39.1% Jan 1, 2018 Mar 31, 2018
Q4 2017 -75.8 +4.44 +5.53% Oct 1, 2017 Dec 31, 2017
Q3 2017 -81.4 -11.3 -16.1% Jul 1, 2017 Sep 30, 2017
Q2 2017 -85 -28.8 -51.2% Apr 1, 2017 Jun 30, 2017
Q1 2017 -97.4 -55.6 -133% Jan 1, 2017 Mar 31, 2017
Q4 2016 -80.2 -45.1 -128% Oct 1, 2016 Dec 31, 2016
Q3 2016 -70.1 -35.7 -104% Jul 1, 2016 Sep 30, 2016
Q2 2016 -56.2 -20.8 -58.6% Apr 1, 2016 Jun 30, 2016
Q1 2016 -41.8 -6.51 -18.5% Jan 1, 2016 Mar 31, 2016
Q4 2015 -35.1 +10.9 +23.7% Oct 1, 2015 Dec 31, 2015
Q3 2015 -34.4 +13.4 +28% Jul 1, 2015 Sep 30, 2015
Q2 2015 -35.5 +27.2 +43.4% Apr 1, 2015 Jun 30, 2015
Q1 2015 -35.3 +97.8 +73.5% Jan 1, 2015 Mar 31, 2015
Q4 2014 -46 +64.2 +58.2% Oct 1, 2014 Dec 31, 2014
Q3 2014 -47.8 +76.9 +61.7% Jul 1, 2014 Sep 30, 2014
Q2 2014 -62.6 +32.5 +34.2% Apr 1, 2014 Jun 30, 2014
Q1 2014 -133 -33.3 -33.3% Jan 1, 2014 Mar 31, 2014
Q4 2013 -110 +36.5 +24.9% Oct 1, 2013 Dec 31, 2013
Q3 2013 -125 -67.2 -117% Jul 1, 2013 Sep 30, 2013
Q2 2013 -95.1 +48.7 +33.9% Apr 1, 2013 Jun 30, 2013
Q1 2013 -99.8 +215 +68.3% Jan 1, 2013 Mar 31, 2013
Q4 2012 -147 Oct 1, 2012 Dec 31, 2012
Q3 2012 -57.5 Jul 1, 2012 Sep 30, 2012
Q2 2012 -144 Apr 1, 2012 Jun 30, 2012
Q1 2012 -315 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.